Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022)
Ardelyx (ARDX) posted Depreciation and Depletion of $175000.0 for Q2 2022, down 24.57% on a QoQ basis from $232000.0 in Q1 2022, and down 52.05% year-over-year from $365000.0 in Q2 2021.
Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022) Analysis & Trends
Ardelyx's Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $175000.0 for Q2 2022.
- Quarterly Depreciation and Depletion fell 52.05% year-over-year to $175000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1.0 million (down 37.31% YoY) and the FY2025 annual result came in at $800000.0, up 60.0% from the prior year.
- Depreciation and Depletion was $175000.0 for Q2 2022 at Ardelyx, down from $232000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $678000.0 in Q2 2019 and bottomed at $153000.0 in Q4 2021.
- A 5-year average of $488111.1 and a median of $480000.0 in 2020 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2018 — Depreciation and Depletion gained 13.47% — and 2021, when it slumped 61.85%.
- Ardelyx's Depreciation and Depletion stood at $673000.0 in 2018, then decreased by 24.52% to $508000.0 in 2019, then dropped by 21.06% to $401000.0 in 2020, then slumped by 61.85% to $153000.0 in 2021, then rose by 14.38% to $175000.0 in 2022.
- Business Quant data shows ARDX's Depreciation and Depletion at $175000.0 in Q2 2022, $232000.0 in Q1 2022, and $153000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 175,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Mar 31, 2020 | 492,000.00 |
| Mar 31, 2020 | 492,000.00 |